Pioneering research and development on the TruScreen system for real-time cervical tissue differentiation has involved close collaboration with leading clinicians and hospitals across the world.
TruScreen’s development began in the late 1980s under the guidance of leading medical academics from Sydney University who sought to establish objective technology that could improve on the conventional Pap test. They believed that it should be possible to distinguish between normal and abnormal tissue by measuring changes in physical properties, such as electrical potential.
After almost 20 years in the R&D phase TruScreen was developed using the ‘Opto Electrical’ Technology for the detection of cancerous cells on cervix. TruScreen contains a sophisticated algorithm framework that has been developed in collaboration with the Australian Government’s applied research division, CSIRO.
TruScreen has been honoured with a range of technology and engineering awards, such as the Australian Design Awards in 2002 for engineering design and a further award for software electronics design. TruScreen was also highlighted in the 2004 Australian Government publication ‘Imagination – 100 Years of Bright Ideas in Australia’.
The TruScreen system has a strong range of patents across many countries for its real-time tissue classification from signal inputs using proprietary algorithms.